Pharmaceutical Limits in Therapeutic Options

*Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology*

[36] Donovan JW. Ultraviolet difference spectroscopy–New techniques and applications. Methods in Enzymology. 1973;**27**:497-525. PubMed PMID:

[37] Crismon ML. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease. Pharmacotherapy. 1998; **47-54**:79-82. Review. PubMed PMID:

4773294

9543465

drug complexation with a globular protein in different aqueous media. Colloids and Surfaces. B, Biointerfaces. 2008;**63**(2):217-228. PubMed PMID:

Diamantoglou S, Sedaghat-Herati MR, Nafisi S, Carpentier R, Tajmir-Riahi HA. The effects of drug complexation on the stability and conformation of human serum albumin: Protein unfolding. Cell Biochemistry and Biophysics. 2006;**45**(2):203-213. Review. PubMed

[31] Wen ZM, Ye ST. Skin testing in patients with high risk of anaphylactic reactions to penicillin. Asian Pacific Journal of Allergy and Immunology. 1993;**11**(1):13-18. PubMed PMID:

[32] Takeda K, Wada A, Yamamoto K, Hachiya K, Batra Prem P. Secondary structure change of myoglobin induced by sodium dodecyl sulfate and its kinetic aspects. Journal of Colloid and Interface Science. 1988;**125**(1):307-313.

Available online 21 July 2004

[33] Bogoeva VP, Radeva MA,

[34] Monsellier E, Bedouelle H. Quantitative measurement of protein stability from unfolding equilibria monitored with the fluorescence maximum wavelength. Protein Engineering, Design & Selection. 2005;**18**(9):445-456. PubMed PMID:

[35] Vivian JT, Callis PR. Mechanisms of tryptophan fluorescence shifts in proteins. Biophysical Journal. 2001;**80**(5):2093-2109. PubMed PMID:

PMID: 15134654

Atanasova LY, Stoitsova SR, Boteva RN. Fluorescence analysis of hormone binding activities of wheat germ agglutinin. Biochimica et Biophysica Acta. 2004;**1698**(2):213-218. PubMed

[30] Ahmed-Ouameur A,

18222070

PMID: 16757821

8216554

**72**

16087653

11325713

**75**

**Chapter 5**

**Abstract**

environment.

treatment, carer

**1. Introduction**

of Alzheimer's

*Terezia Fertalova and Iveta Ondriova*

**Keywords:** Alzheimer's disease, memory, non-pharmacological,

non-pharmacological treatment of dementia.

tia patients and their family members [1].

Non-pharmacological Treatment

Caring for a patient with dementia is challenging, as we cannot cure Alzheimer's disease but only slow its progress. In the presented chapter, we offer non-pharmacological approaches for influencing the patient's behaviour, actions and emotions, and to arouse their interest and motivation, while preserving the highest quality of life. In the past, many experts have looked at specific approaches to dementia patients and devoted their entire professional lives to senior citizens. Our aim is to offer an overview of the most frequently used therapeutic approaches with dementia patients and use practical demonstrations to reinvigorate the theoretical basis. At the end of the chapter we deal with the burden on the carer in the family

With the increasing number of seniors, the number of newly diagnosed patients with dementia syndrome, including Alzheimer's disease, is rising. At the same time, the costs of treatment are increasing. This has led experts to focus on less costly,

Examining non-pharmacological approaches to patients with dementia and their family carers does not have such a long tradition or history as the scientific examination of pharmacological approaches. Certainly, scientists have always taken it as given that besides pharmacotherapy, it is useful to activate, reassure, adapt the environment and other procedures experienced by non-medical staff in particular. These procedures have long been considered appropriate and useful, but not too stimulating or interesting for further scientific research. However, in the last decade, work has appeared examining non-pharmacological approaches to demen-

The goal of non-pharmacological treatment is to maintain or improve the level of gross and fine motor skills, walking, self-sufficiency and cognitive functions. At the same time, another goal is to meaningfully fill free time and to influence the symptoms of dementia and activities of daily life, to improve verbal and non-verbal

The activities we choose must be appropriate to the condition of the sufferer. There are multiple non-pharmacological approaches; the therapist selects from a spectrum of options, taking into account the age of the patient, the stage of the disease, the gender, therefore it is necessary to emphasize the individual approach.

communication between the sufferer and their relative or nurse….
